Brief: Neovacs' EGM Allows Funding Programme, Implementation Of Strategic Plan
10/07/2020 07:27
July 10 - NEOVACS SA ALNEV.PA :
* ANNOUNCED ON THURSDAY THAT EGM HAS VALIDATED FUNDING
PROGRAMME
AND ALLOWS IMPLEMENTATION OF STRATEGIC PLAN
* LIFTING OF CONDITION PRECEDENT PRIOR TO IMPLEMENTATION OF
NEW
OCEANE-BSA FINANCING AGREEMENT IN THE MAXIMUM NOMINAL AMOUNT OF
40 MLN EUROS urn:newsml:reuters.com:*:nFWN2CZ01K
Source text for Eikon: ID:nACT64252
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 778 51 10;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants